Ardelyx, Inc. (ARDX)
6.19
-0.08
(-1.28%)
USD |
NASDAQ |
Mar 06, 16:00
6.15
-0.04
(-0.65%)
After-Hours: 20:00
Ardelyx Research and Development Expense (TTM) : 68.47M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Ionis Pharmaceuticals, Inc. | 914.12M |
| MannKind Corp. | 66.35M |
| Vertex Pharmaceuticals, Inc. | 3.929B |
| PTC Therapeutics, Inc. | 455.25M |
| Fate Therapeutics, Inc. | 94.93M |